NP-G2-044 as Monotherapy and Combination Therapy in Patients With Advanced or Metastatic Solid Tumor Malignancies
Clinical trial NCT05023486 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05023486
- Sponsor
- Novita Pharmaceuticals, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-07
- Primary completion
- 2026-06-30
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.